PTC Therapeutics | PTCT - Stock

Stock Price
71.47
Daily Change
-1.25 -1.72%
Monthly
-0.32%
Yearly
55.34%
Q2 Forecast
70.03

PTC Therapeutics reported $75.57M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 31.57M 3.1M Mar/2026
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
Amgen USD 6.19B 39M Mar/2026
BioCryst Pharmaceuticals USD 5.98M 587K Mar/2026
Biogen USD 1.95B 219.1M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Daiichi Sankyo JPY 608.55B 93.64B Sep/2025
Esperion Therapeutics USD 104.21M 915K Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Incyte USD 115.62M 14.56M Mar/2026
Ionis Pharmaceuticals USD 5.56M 4.49M Mar/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Novartis USD 6.29B 17M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
PTC Therapeutics USD 75.57M 4.08M Mar/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sarepta Therapeutics USD 1B 86.37M Mar/2026
TG Therapeutics USD 129.03M 3.44M Mar/2026
Ultragenyx Pharmaceutical USD 55M 3M Mar/2026
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026